🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is conducted in Oceania. A phase 2a study to assess the effect o...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2004-09
Trial ID
NCT00336986
Treatments Being Tested
This phase 1/2a trial is conducted in Europe. The first part of the trial i...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2007-07-12
Trial ID
NCT00617253
This phase I/II trial studies the side effects and best dose of donor natur...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2014-05-19
Trial ID
NCT01787474
The purpose of this study is to determine whether the combination of the 2 ...
Status
Completed
Location
Oncology Research Associates, Pllc D/B/A
Start Date
2012-06
Trial ID
NCT01629758
Treatments Being Tested
This phase 1, first-in-human study uses a BOIN design to assess the safety ...
Status
Unknown
Location
Taipei Medical University -Shuang Ho Hospital
Start Date
2022-02-28
Trial ID
NCT05296772
The purpose of the study is to evaluate whether recombinant IL-21 used in c...
Status
Completed
Location
University of California, Los Angeles
Start Date
2006-06
Trial ID
NCT00347971
Treatments Being Tested
RATIONALE: Interleukin-21 may stimulate white blood cells, including natura...
Status
Completed
Location
Cross Cancer Institute
Start Date
2007-12-13
Trial ID
NCT00514085
This study is being done to see if an experimental drug called recombinant ...
Status
Completed
Location
University of Michigan Comprehensive Cancer Center
Start Date
2004-05
Trial ID
NCT00095108
Treatments Being Tested